| INTRODUCTION
The conserved oligomeric Golgi (COG) complex is a master regulator of membrane trafficking at the Golgi. [1] [2] [3] [4] [5] [6] [7] [8] [9] The COG complex influences a variety of processes through its many interactions with trafficking machinery. The most noted effect of COG deficiency is misglycosylation. [10] [11] [12] [13] In fact, the deficiency /malfunction of the COG complex in humans is classified as a congenital disorder of glycosylation type II (COG-CDG) or a CDG affecting multiple pathways. 10, [14] [15] [16] [17] [18] [19] [20] CDGs are a heterogeneous group of disorders with a wide variety of phenotypes dependent on the protein affected and the severity of the mutation in the affected protein. CDG patients are often identified because of an unexplained early onset of symptoms that have no traditional explanation, leading to genetic testing or to serum glycan profiling if a CDG is suspected. A CDG is confirmed if serum proteins transferrin and apolipoprotein E (ApoE) (Nand O-glycosylated, respectively) are found to be underglycosylated.
If transferrin alone is affected then a CDG-N-linked is diagnosed, if
both are underglycosylated the patient has CDG-multiple pathway
disorder. Patients with CDG-multiple pathway disorders can have
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Though COG patients fit the diagnostic criteria for a CDG (having underglycosylated proteins/lipids), the COG complex is different from most proteins whose mutations cause CDGs in that it is primarily a vesicle trafficking molecule and not a glycosylation enzyme or sugar transporter, meaning its impact on glycosylation is secondary. 24 We thus reasoned that COG-deficient patients would not only have defects related to misglycosylation but also trafficking-related defects that are independent of misglycosylation.
In order to elucidate COG's role at the cellular level, we previously created CRISPR-mediated KOs of each COG subunit in human HEK293T cells and characterized these cells extensively. 25 We found that deficiency in any COG subunit caused severe misglycosylation, similar to that seen in patient samples. In addition, trafficking disturbances as well as Golgi structure abnormalities were present in all COG subunit KOs. These changes overlapped well with findings in COG-CDG patient fibroblasts and COG-deficient CHO cells. [26] [27] [28] In this study, we sought to uncover which of these COG KO phenotypes were downstream of hypoglycosylation and which were independent of it. To answer this question, we chose to knockout 2 nonredundant genes: Alpha-1,3-mannosyl-glycoprotein 2-beta-Nacetylglucosaminyltransferase (MGAT1) and uridine diphosphate- There has yet to be a patient identified with an MGAT1 mutation, but MGAT1 KO in mice was found to be embryonic lethal, probably because of neural tube closure defects indicating the severity of the glycosylation defects produced when this enzyme is absent. [32] [33] [34] GALE deficiency was first characterized in CHO cells, where it was found to be an essential gene for low-density lipoprotein (LDL) receptor stability, and was thus named LDLD. 35 These cells were later shown to have a mutation in the gene encoding GALE, an epimerase that interconverts glucose and galactose as well as GalNAc and
GlcNAc in the cytosol. 36 In humans, mutations in GALE cause galac- 2 | RESULTS
| COG KO affects stability of key Golgi glycosylation enzymes in HEK293T cells
We and others 1, 6, [11] [12] [13] [38] [39] [40] [41] [42] [43] [44] [45] have proposed that COG deficiencies are affecting glycosylation via regulation of intra-Golgi trafficking of Golgi glycosylation machinery. Intracellular localization of MGAT1 13, 39, 40 and MAN2A1/Mann II 13, 46 was previously shown to be severely affected in HeLa cells transiently knocked down for COG complex subunits. Previously, we also reported that sialylation and fucosylation are decreased in COG KO cells while terminal mannose residues are increased. 12 To gain a better understanding of which glycosylation enzymes are affected in COG KOs, we probed knockout lysates for key glycosylation enzymes by WB. We found that nearly all tested Golgi enzymes are COG sensitive ( Figure 1 ). In COG KO cells, MGAT1, B4GalT1 and ST6Gal1 are all dramatically decreased in abundance, while B4galT5 appears to be insensitive to COG malfunction ( Figure 1A,B) .
We then decided to select a pair of nonredundant glycosylation- To further assess glycosylation defects in MGAT1, GALE and COG KO cells, we used sugar-specific lectins to probe both total cellular and plasma membrane expressed glycoconjugates. For these assays, a subset of COG KOs was chosen, including subunits from lobe A (COG2 and COG4) and B (COG7) of the COG complex. We previously showed that these knockouts all have similar glycosylation and trafficking phenotypes, so these subsets are representative of whole complex malfunction. 12 Lectins chosen for this characterization were Galanthus nivalis lectin (GNL), Griffonia simplicifolia lectin 
| COG KO specifically affects Golgi structure
We next sought to test if dramatic altering of glycosylation observed in MGAT1 and GALE knockouts would alter Golgi structure, as the COG subunit KOs do. For this assessment, we employed superresolution fluorescent microscopy which allowed us to distinguish the fragmented Golgi structures in COG KO cells from control HEK293T
Golgi ribbon structures ( Figure 4 ) that we have previously observed by electron microscopy. 25 We used GM130 (a cis-Golgi marker) and To continue our analysis of the relationship between MGAT1
and GALE KO cell phenotypes to COG KO cell phenotypes, we wanted to ensure that COG complex localization itself was not disturbed by MGAT1 or GALE depletion. As shown in Figure 5 
| COG KO specifically affects endolysosomal structure
Surprisingly, in COG KO cells, in addition to Golgi fragmentation, we also observed dramatic alterations of the endosomal/lysosome system. Upon KO of any COG subunit, enlarged vacuolar structures, some being in excess of 5 μm across, were readily visible by differential interference contrast (DIC) microscopy ( Figure 6A ). Upon further characterization, we discovered that these structures immunostained with endogenous lysosomal protein Lamp2 ( Figure 6B ), as well as with Rab7 and CD63 (J. Blackburn, V. Lupashin, unpublished observation), indicating that they are late-endosomal and/or lysosomal in origin. We next sought demonstrate that the enlarged structures visible by DIC microscopy were the same Lamp2-positive structures in fixed and stained cells. To answer this, we transiently transfected COG KO cells with a Lamp2-GFP plasmid and then imaged cells using fluorescence and DIC microscopy, simultaneously. As shown in Figure 6C , the all vacuoles seen in DIC were also labeled with Lamp2-GFP in transfected cells ( Figure 6C ). We will further refer to these COG KOinduced compartments as enlarged endolysosomal structures (EELSs).
These EELSs were not seen in MGAT1 or GALE cells ( Figure 6A ,B), indicating that this is probably an effect of defective endosomal/ FIGURE 2 CRISPR/Cas9-induced KO of MGAT1 and GALE results in severe Lamp2 glycosylation and stability defects. A, WB analysis of HEK293T cells depleted for MGAT1 and GALE. B, MGAT1, GALE and COG KO CL were analyzed for Lamp2 glycosylation and stability. All KOs show increased Lamp2 gel mobility indicating hypoglycosylation. C, Quantification of Lamp2 abundance in KO cells vs control (n = 3). *Significant difference from WT levels where P < .05. Protein levels are expressed in AUs with WT being 100%. Actin was used as a loading control
Golgi trafficking due to COG specific malfunction and not a byproduct of hypoglycosylation of lysosomal, Golgi or trafficking proteins.
| COG KO affects retrograde trafficking while MGAT1 and GALE KOs do not
After verifying that MGAT1 and GALE glycosylation mutants did not have any unintended/unexpected effects on Golgi structure or on the COG complex that could interfere with our comparisons, we next sought to determine if impaired glycosylation results in trafficking disturbances. It has previously been extensively reported that the COG complex is involved in retrograde trafficking at the Golgi. 39, [55] [56] [57] This has been demonstrated by both resistance of Golgi collapse upon Brefeldin A treatment in COG-deficient cells 14, 24, 58 and defects in Shiga toxin and Subtilase cytotoxin (SubAB) trafficking. cleaved in GALE KO cells; see Figure 7B ), while in COG2 KO cells it takes an additional hour to obtain the same degree of cleavage (58% cleavage at 90 minutes; see Figure 7B ). This suggests that COG's effect on retrograde trafficking extends outside of its effects on glycosylation.
| COG KOs alone cause perturbations in sorting and overall secretion
To further assess if the COG KO effects on the efficiency of intracellular trafficking were related to hypoglycosylation, we next tested protein sorting in MGAT1 and GALE KO cells as well as COG KO cells using secretion of lysosomal protease cathepsin D. At the To further understand the impact that COG KO was having on
Golgi sorting and secretion compared with MGAT1 and GALE Kos, we collected and analyzed total proteins secreted into the conditioned media compared to proteins contained in CL ( Figure 9A ).
While GALE KO cells did demonstrate slightly enhanced secretion and GALE proteins ( Figure 10A ). G/M DKOs were then assessed for Lamp2 stability and mobility (Figure 10A ). In G/M DKO cells, Lamp2
showed a similar mobility to the MGAT1 single KO, and increased mobility when compared to the GALE single KO. However, similar to the GALE single KO, the stability of Lamp2 was reduced in the G/M DKO cells, confirming our hypothesis that the hypermobility of In contrast, COG KO cells showed a severely dysmorphic Golgi, as we have previously observed in these cells. 25 This suggests that maintenance of Golgi structure is not dependent on Golgi 2.9 | COG7-CDG patient fibroblasts have altered endolysosomes and defects in sorting/secretion
To further investigate and confirm these COG KO specific changes in another COG-deficient cell line, we characterized COG7-CDG fibroblasts-obtained from a COG7-CDG patient-that were previously shown to have far less COG7 protein than control fibroblasts. 61 Similar to their CRISPR KO counterparts, large 1-5 + μm intracellular vacuole-like structures were visible by phase contrast microscopy in Figure 12D ). We also analyzed the conditioned media for COL6A1, a normal secretory product of fibroblasts. We found that its secretion was also increased in the COG7-CDG cells around 3× that of control fibroblasts ( Figure 10D ). This was not due to cell lysis, as there was little/no alpha tubulin in the concentrated media. In addition, TGN transmembrane protein GPP130 was not found in the conditioned media, even though it is COG sensitive, as previously reported, 54 showing that the altered secretion and sorting are specific for a subset of proteins.
Taken together, this strongly suggests that COG deficiency causes COG specific, glycosylation-independent defects in Golgi sorting, lysosomal morphology and altered secretion, not only in our KO model, but also in COG7-CDG patient derived cells.
| DISCUSSION
In this study, we sought to determine which phenotypic changes in COG-deficient cells are an effect of hypoglycosylation of transmembrane and secretory proteins and which are more specific to other COG functions.
In all studied eukaryotic systems, COG complex malfunction affects N-and O-glycosylation through mistrafficking of glycosylation enzymes, 38, 40, [62] [63] [64] but in addition to this wide-spread defect, several trafficking regulators (v-SNAREs Bet1L/GS15 and GOSR1/GS28) as FIGURE 7 Retrograde trafficking is impaired in COG KO cells but not MGAT1 or GALE. Cells were treated with SubAB for the indicated time-points at 37 C then collected and lysed. Samples were analyzed by WB (A, FL = full length GRP78) and quantified using fluorescent densitometry for cleavage of SubAB target protein GRP78/Bip (B). SubAB takes~60 minutes longer to reach the ER and cleave GRP78 in COG KO cells than MGAT1 or GALE KO cells (n = 2). *Significance from MGAT1 values; # significance from GALE values. MGAT1
and GALE were not statistically significant from one another, P < .05. Error bars represent SD Thus, we reasoned that some of the phenotypes we observe must be related to COG-specific trafficking functions that are not related to hypoglycosylation. We then postulated that, if this were true, it would have important implications for broadening our understanding of how defects in intra-Golgi trafficking specifically related to COG function impact the cell. In addition, uncovering COG-dependent phenotypes unrelated to glycosylation defects would broaden our understanding of COG-CDGs, as these cellular phenotypes could cause symptoms that are atypical of other CDGs and, therefore, require different treatments.
To test this hypothesis, we created mutants that show Golgibased defects in glycosylation similar to or more severe than the ones observed in COG KO cells. MGAT1 and GALE were chosen for this purpose as they created early and late blocks in N-glycosylation, respectively. GALE KO also prevented O-glycosylation by removing A subset of glycosylation-independent COG KO phenotypes could arise as a secondary manifestation of permanent Golgi fragmentation.
Golgi fragmentation has an important physiological role in mitosis. 68 Golgi fragmentation has also been observed to proceed apoptosis, alter FIGURE 9 Protein secretion is stimulated in COG KO cells. MGAT1, GALE and COG KOs were placed in serum-free media for 36 hours. Media were then collected and concentrated 5×, and cells were collected and lysed. Ten microliters of media (A, Med) and CL (A, CL) were analyzed for protein abundance via Coomassie blue stain (A) and GNL lectin and tubulin blots (C). Tubulin blot was used as a loading control and to ensure that minimal lysis was present in conditioned media. B, Total protein amount secreted was quantified and standardized to WT (n = 4, COG2 n = 2). *Significance from WT, P < .05. Error bars represent SD cell migration and impair polarized secretion. 69 Persistent fragmentation has been noted pathological states, such as cancers (eg, GOLPH3
is a well-known oncogene, and its overexpression in cancer cells has been linked to Golgi fragmentation and enhanced cell proliferation 70 ), pathogenic infection (eg, Chlamydia remodels the Golgi in later stages on infection 71 ) and neurological diseases (Golgi fragmentation has been observed in Alzheimer's disease, ALS, Parkinsons and Creutzfeldt-Jacob disease 69, 72, 73 ). Fragmentation of the Golgi in cancer has been theorized to proceed cancer cells becoming more metastatic. 74 Golgi fragmentation in neurodegenerative disorders contributes to the pathology of these disease by causing defective protein processing and sorting and eventually leads to neuronal death. 75 Persistent Golgi fragmentation was seen in all COG KO cells. COG KO Golgi was swollen and vesiculated and far less stacked/organized than control or MGAT1/ GALE DKO cells (Figure 10 and Reference 25). This is potentially due to a disbalance between anterograde and retrograde trafficking, but could also be due to changes in lipid compositions affecting Golgi membrane curvature or altered levels of pH or calcium at the Golgi affecting the lumen and inducing swelling. 26, [76] [77] [78] What specific alterations in COG KO cells are causing this persistent fragmentation, and how this fragmentation contributes to other phenotypes observed in COG KO cells will be an important avenue for future investigation.
Interestingly, our recent experiments with permanent attachment of COG subunits to the Golgi membrane indicate that the expression of Golgi-restricted COG4 and COG7 was sufficient to block EELS accumulation but failed to rescue Golgi fragmentation in COG KO cells. 79 At the same time, Golgi attached COG subunits was sufficient for restoring normal cathepsin D sorting, indicating that some glycosylation-independent phenotypes in COG KO cells may not be directly related to Golgi fragmentation. 80 and select lysosomal storage disorders, 82 we do not believe this to be the case in COG deficiency. COG KO cells demonstrate the normal distribution of the mannose-6-phosphate cation independent receptor. 25 We have also observed no change in the cationdependent M6P receptor localization (data not shown). In agreement with this conclusion, previous studies of COG7-CDG patients demonstrated an increase in secreted lysosomal enzyme activity with a normal level of mannose-6-phosphate. 83 This study also showed no effect on M6PR-CI distribution in patient fibroblasts, indicating that this missorting exists in COG KO cells as well as
patient cells and appears to be independent of M6P tagging or receptor localization for both. So, what is causing the secretion of , and α-tubulin (E). Col6A1 and cathepsin D were secreted 3× more in COG7-CDG patient cells than control (n = 2, calculated via densitometry), while transmembrane protein GPP130 was not secreted in either. α-Tubulin was used as a control for lysis. Scale bar is 5 μm COG deficiency has been shown to affect localization and stability of several ion transporters such as ATP7A and SLC31A1 86 ), thus changing the ion concentrations at the Golgi, which are known to be important for retention of sorting molecules such as GPP130 (COG sensitive), 54 TMEM165 and Cab45. 60 The COG complex is a master co-ordinator of trafficking components and functionally interacts with several trafficking components at the TGN including members of the GARP/EARP complex, the STX6/STX16/Vamp4/Vti1a SNARE complex and GOLPH3. 4, 64 Deficiency of the COG complex could either cause these components to be mislocalized and/or destabilized, as is the case of VAMP4 in COG8-deficient patient cells. 87 COG deficiency could also make these trafficking interactions less efficient as it was the case for STX16 SNARE complex formation in COG-deficient fibroblasts of COG knockdown in HeLa cells. These changes then lead to altered cycling between the TGN and endosomes, 87 which could affect the steady state protein composition at the Golgi thus altering sorting.
In summary, we have found that the majority of COG KO phenotypes previously reported by our laboratory were not due to Golgibased glycosylation defects mimicked by GALE and MGAT1 deficiency, but rather due to other more COG specific trafficking roles.
We hope that these cellular insights will shed light, not only on COG facilitated membrane trafficking, but also on the heterogeneity of COG-CDG patient symptoms and perhaps eventually lead to different or better ways to manage these symptoms. Other reagents include SubAB (1.49 mg/mL), a gift from Dr. J. Paton. 
| Antibodies and reagents

| Cell lysis and WB analysis
Cells were lysed in hot 2% SDS and heated for 5 minutes, and then the 6× SDS sample buffer with β-mercaptoethanol (βME) was added to samples. Then samples were mixed and frozen until needed. For WB analysis, the samples were loaded into Bio-Rad 4%-15% gels or 7% or 9% laboratory-made gels. Gels were then transferred to nitrocellulose paper using the Thermo Scientific Pierce G2 Fast Blotter.
Membranes were rinsed in PBS and then blocked using a Odyssey blocking buffer for 20 minutes. Then primary antibody was added and incubated overnight at 4 C. Membrane was then washed with PBS and then incubated with Licor IRDye secondary antibodies in 680 and 800 CW in 5% milk in PBS for 45-60 minutes. Blot was then washed and imaged using the Odyssey Imaging System. Images were processed using the Licor Image Studio software.
| Lectin blot
Lectins (described under antibodies and reagents) were conjugated to Alexa647 fluorophore, which can be detected by the Odyssey. The membranes were blocked with blocking buffer or 3% BSA then lectin was added, and the membrane was incubated for 1 hour at room temperature or overnight at 4 C then washed and imaged. 
| Secretion assay
Cells were plated in 6-well plates and grown to 90%-100% confluency. They were then rinsed carefully with DPBS 5×, then plated in 1 mL of serum-free, chemically defined media (BioWhittaker Pro293a-CDM, Lonza) with 1× GlutaMAX (100× stock, Gibco) added per well. They were kept in media for 24-36 hrs, then the media were collected and spun down to remove floating cells. Supernatant was transferred to a new tube and then concentrated using a 10-k concentrator (Amicon Ultra 10 k, Millipore), and the final concentration was 5-10× that of CL. The cells were collected separately in PBS and spun down. Supernatant was removed and the cells were lysed in hot 2% SDS. The samples were analyzed by WB as detailed earlier.
| SubAB trafficking assay
SubAB assay was performed essentially as previously described 55 with minor changes. Each cell line was plated in 1 well of a 6-well plate and allowed to grow to 70%-80% confluency. Media were removed and replaced with 500 μL of fresh media (as described above, with no antibiotics or antimycotics). A 6× stock of SubAB in media was then made (39.3 μg/mL). 100 μL of stock solution was added to each well at the appropriate time-point for a final concentration of 6.5 μg/mL. Time-points were 180, 120, 90, 60, 30 and 0 minutes with the toxin. Cells were incubated with the toxin for the appropriate amount of time at 37 C in 5% CO 2 with 90% humidity.
At the end, media with toxin were collected and disposed of in bleach, and the cells were collected in DPBS and spun down at 600×g for 3 minutes. Supernatant was removed, and the cells were lysed in 2% SDS. Lysates were analyzed for GRP78 using the WB protocol as detailed earlier. Actin was used as a loading control for quantification.
4.9 | High pressure freezing, freeze substitution and electron microscopy
Electron microscopy for Figure 10 was performed as described in Electron microscopy for Figure 12 was performed as previously described. 25 Briefly, cells were plated on a sapphire disk to be at Postcutting staining was done with uranyl acetate and lead citrate prior to imaging.
In Figures 10 and 12 , ultrathin sections were imaged at 80 kV on an FEI Technai G2 TF20 transmission electron microscope. The images were taken with an FEI Eagle 4kX USB Digital Camera.
| Statistical analysis
All the results are representative of at least 3 independent experiments unless noted. WBs are the representative images from 3 repeats. They were quantified via densitometry using the Licor Image Studio software. Error bars for all graphs were calculated based on SD. P values were calculated using a 2-tailed students t test. The significance was defined as P < .05. The arbitrary units were defined in each figure. 
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